SynthesisPsycho-oncology2026
Determinants of Interest-Holder Perspectives Toward Post-Mortem Tissue Donation in Oncology: A Systematic Review.
Synthesis in Psycho-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivePost-mortem tissue donation (PTD) is increasingly recognised as an important resource for advancing cancer research. Developing effective recruitment strategies for PTD programs requires a thorough understanding of interest-holder perspectives, which remain insufficiently explored. This systematic review examined factors influencing patients' willingness to participate in PTD, next-of-kin's willingness to support their relative's participation, and healthcare professionals willingness to recruit for PTD programs.
methodsA systematic literature search was conducted on 19 February 2026 to identify original research studies exploring self-reported factors influencing perspectives toward PTD. Study selection, data extraction, and quality appraisal were performed independently by four reviewers. Identified factors were synthesised and categorised into five domains: ethical/existential, emotional, practical, socio-demographic/socio-economic, and disease-related.
resultsFourteen studies were included from 11,986 records screened. Overall, attitudes toward PTD were generally favourable across interest-holders. Ethical, existential and emotional considerations, particularly altruism, reciprocity and the perceived impact on the patient-clinician relationship were associated with willingness to participate in, (support) consent to, or recruit for PTD. Reported barriers were predominantly practical, including logistical challenges, concerns regarding funeral arrangements, and limited knowledge of PTD procedures. Healthcare professionals additionally identified discomfort with end-of-life discussions and uncertainty about PTD processes as barriers to recruitment. Socio-demographic, socio-economic, and disease-related factors were reported inconsistently, with no clear pattern of association.
conclusionsInterest-holder attitudes toward PTD are primarily shaped by ethical, emotional, and practical considerations. The consistency of findings across interest-holder groups and cancer types supports the development of patient-centred communication strategies to facilitate the implementation of PTD programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.